Literature DB >> 32283292

Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients.

Konstantin Schlaaff1, Henrik Dobrowolny2, Thomas Frodl3, Christian Mawrin4, Tomasz Gos5, Johann Steiner6, Bernhard Bogerts7.   

Abstract

An increasing number of clinical, epidemiological and genetic studies as well as investigations of CSF and blood suggests that neuroinflammation plays an essential role in the etiology of schizophrenia and mood disorders. However, direct neuropathological evidence of inflammation within the brain tissue remains sparse and the regional distribution of lymphocytes as surrogate markers of blood-brain barrier (BBB) impairment has not yet been investigated in this context. Densities of T and B lymphocytes were assessed in coronal whole brain sections of 22 patients with schizophrenia and 20 patients suffering from major depression or bipolar disorder, compared to 20 individuals without neuropsychiatric disorders from the Magdeburg Brain Collection. Cell densities were determined by immunohistochemical staining (anti-CD3 for T cells, anti-CD20 for B cells), followed by automated microscopic image acquisition and analysis. Hierarchical clustering and detailed cluster analysis were performed to detect possible subgroups of patients. Regional distribution was assessed by analysis of color coded mappings based on microsopic scans. Elevated lymphocyte density was found in 7 out of 20 mood disorder patients (adj. p = 0.022; Fisher's exact test, FET), 9 out of 22 schizophrenic patients (adj. p = 0.014; FET) and in 1 of 20 controls (p < 0.005; FET). Several cases showed different patterns of infiltration affecting cortical regions or subcortical white matter, while some presented diffuse infiltration. In two thirds of patients, no increased lymphocyte density could be found. The current findings indicate that lymphocyte infiltration occurs in a greater proportion of schizophrenia and mood disorder patients as compared to healthy controls. Under healthy conditions lymphocytes rarely cross the BBB. Thus, higher densities are considered indicators of neuroinflammation associated with an impairment of the BBB.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32283292     DOI: 10.1016/j.bbi.2020.04.021

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

1.  The Effects of Peripheral Inflammation on the Brain-A Neuroimaging Perspective.

Authors:  Caitlin E Millett; Katherine E Burdick; Marek R Kubicki
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

2.  Transcriptome Analysis of Post-Mortem Brain Tissue Reveals Up-Regulation of the Complement Cascade in a Subgroup of Schizophrenia Patients.

Authors:  Eva Lindholm Carlström; Adnan Niazi; Mitra Etemadikhah; Jonatan Halvardson; Stefan Enroth; Craig A Stockmeier; Grazyna Rajkowska; Bo Nilsson; Lars Feuk
Journal:  Genes (Basel)       Date:  2021-08-13       Impact factor: 4.096

Review 3.  TREGking From Gut to Brain: The Control of Regulatory T Cells Along the Gut-Brain Axis.

Authors:  Juli Choi; Bo-Ram Kim; Begum Akuzum; Leechung Chang; June-Yong Lee; Ho-Keun Kwon
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 4.  Blood-Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder.

Authors:  Shusheng Wu; Yuye Yin; Longfei Du
Journal:  Cell Mol Neurobiol       Date:  2021-10-12       Impact factor: 4.231

5.  Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance.

Authors:  Jerry Guintivano; Karolina A Aberg; Shaunna L Clark; David R Rubinow; Patrick F Sullivan; Samantha Meltzer-Brody; Edwin J C G van den Oord
Journal:  Mol Psychiatry       Date:  2022-04-01       Impact factor: 13.437

6.  Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia.

Authors:  Tertia D Purves-Tyson; Kate Robinson; Amelia M Brown; Danny Boerrigter; Helen Q Cai; Christin Weissleder; Samantha J Owens; Debora A Rothmond; Cynthia Shannon Weickert
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 7.  Inflammatory Markers in Substance Use and Mood Disorders: A Neuroimaging Perspective.

Authors:  Khushbu Agarwal; Peter Manza; Marquis Chapman; Nafisa Nawal; Erin Biesecker; Katherine McPherson; Evan Dennis; Allison Johnson; Nora D Volkow; Paule V Joseph
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 5.435

8.  Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives.

Authors:  Evgeny A Ermakov; Mark M Melamud; Valentina N Buneva; Svetlana A Ivanova
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

9.  Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networks.

Authors:  Zixuan Wu; Zhixiang Cai; Hongshuo Shi; Xuyan Huang; Minjie Cai; Kai Yuan; Peidong Huang; Guoqi Shi; Tao Yan; Zhichao Li
Journal:  Aging (Albany NY)       Date:  2022-04-25       Impact factor: 5.682

10.  Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio in Depression: An Updated Systematic Review and Meta-Analysis.

Authors:  Yanwei Cheng; Yiwen Wang; Xiangyi Wang; Zhuoya Jiang; Lijun Zhu; Shaokuan Fang
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.